Td Private Client Wealth LLC Kymera Therapeutics, Inc. Transaction History
Td Private Client Wealth LLC
- $4.44 Trillion
- Q3 2025
A detailed history of Td Private Client Wealth LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 12 shares of KYMR stock, worth $716. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12Holding current value
$716% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KYMR
# of Institutions
226Shares Held
72.9MCall Options Held
178KPut Options Held
64.6K-
Price T Rowe Associates Inc Baltimore, MD6.86MShares$410 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.65MShares$397 Million2.94% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.56MShares$391 Million5.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$336 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.5MShares$329 Million9.44% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $3.27B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...